Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,763.00 -13.78 -0.50%
FTSE 100 6,647.72 -49.07 -0.73%
DAX 8,275.09 -76.89 -0.92%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Fund Type: FCP
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

CCR Actions Biotech

+ Add to Watchlist

MERCBIO:FP

385.42 EUR 2.06 0.53%

As of 05:06:00 ET on 05/22/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for CCR Actions Biotech (MERCBIO)

Year To Date: +36.59% 3-Month: +24.80% 3-Year: +23.55% 52-Week Range: 264.78 - 393.70
1-Month: +3.92% 1-Year: +44.24% 5-Year: +15.70% Beta vs CAC: 0.57

Mutual Fund Chart for MERCBIO

No chart data available.
  • MERCBIO:FP 385.42
  • 1M
  • 1Y
Interactive MERCBIO Chart

Previous Close

Fund Profile & Information for MERCBIO

CCR Actions Biotech is an open-end fund registered in France. The Fund invests at least 60 percent of its assets in French and foreign stocks linked to the biotechnology and health technologies sectors. The Fund is hedged against the USD after 09/30/03.

Inception Date: 12-04-1998 Telephone: 33-1-44-56-43-50
Managers: AURELIEN TAIEB
Web Site: www.ubs.com/wm-france

Fundamentals for MERCBIO

NAV (on 2013-05-22) 385.42
Assets (M) (on 2013-05-22) 5.67
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for MERCBIO

No dividends reported

Fees & Expenses for MERCBIO

Front Load 3.00
Back Load 3.00
Current Mgmt Fee 1.40
Redemption Fee 3.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for MERCBIO

Filing Date: 09/28/2012
Name Position Value % of Total
Gilead Sciences Inc 23,858 611,949 9.079%
Biogen Idec Inc 4,762 549,600 8.154%
Amgen Inc 8,235 537,026 7.967%
Celgene Corp 8,673 512,465 7.603%
Onyx Pharmaceuticals Inc 5,280 345,058 5.119%
BioMarin Pharmaceutical Inc 9,867 307,304 4.559%
Vertex Pharmaceuticals Inc 5,950 257,465 3.820%
Regeneron Pharmaceuticals Inc 2,161 255,142 3.785%
Ariad Pharmaceuticals Inc 13,580 254,428 3.775%
Alexion Pharmaceuticals Inc 2,842 251,450 3.730%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil